Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Oh well fun is over

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Sep 13, 2023 4:07pm

148 Views

Post# 35634640

RE:RE:RE:RE:Oh well fun is over

That's what an EDITDA positive Thera with 85M usd sales and 37M net dept, one P3 Nash drug and one P1b Cancer drug, 400M accumulated losses to save income tax of the odrer of over 100M for someone who needs it, 10$ median target from 6 analysts and on and on. It's a joke, it's sick and it make no sense whatsoever.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia